Treatment of Androgenetic Alopecia in Males and Females

Completed · Not applicable

Conditions studied: Androgenetic Alopecia

In brief

The purpose of this study is to evaluate the efficacy of Low Level Laser and Light Therapy system configured in a novel product called the TopHat 655 system, for promoting hair growth in males and females diagnosed with androgenetic alopecia of the head.

Key facts

Study ID

NCT01437163

Run by

Apira Science, Inc.

People needed

88

Starts

2011-09-01

Expected to finish

2013-08-01

Last updated by the study team

2016-07-12

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of androgenetic alopecia
• Fitzpatrick Skin Phototypes I-IV
• Norwood-Hamilton IIa to V for males and Ludwig I or II for females
• Active hair loss within the last 12 months
• Willingness to refrain from using all other hair growth products or treatments
• In overall general good health as determined by the physician investigator

You may not qualify if…

• Photosensitivity to laser light and non-laser LED light operating at 655nms.
• Malignancy in the target treatment area
• Other forms of alopecia of the head
• Past medical history of a collagen-vascular disease, thyroid disease or other cutaneous or systemic disease that seriously effects the scalp
• Unwillingness to remove hair replacement products during the therapy sessions
• Using any medications deemed to inhibit hair growth as determined by the physician investigator

Where it is running

• Adolfo Fernandez-Obregon, MD — Hoboken, New Jersey, United States
• Peter S. Halperin, MD — New York, New York, United States
• Raymond J. Lanzafame, MD — Rochester, New York, United States
• Jeffrey A. Sklar, MD — Woodbury, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.